Endovascular treatment for the common femoral artery: is there a challenger to open surgery?

Deloose, Koen; Martins, Igor; Neves, Caio Athayde; Callaert, Joren

doi:10.23736/s0021-9509.18.10787-7

Cited by 14 publications

(13 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In recent years, there is growing evidence to suggest that percutaneous stents may be a valid option for CFA stenoses (Table 2). [4][5][6][9][10][11][12][13][14][15][16][17][18][19][20][21][22] A major propeller for this momentum change is the invention of newer generations of stents which aim to address the unique challenges of the dynamic forces and atherosclerotic issues of the common femoral artery. Osteoid metaplasia is the formation of lamellar bone-like arterial calcification, characterized by formation of extracellular osteoid matrix composed of osteoblast-and osteoclast-like cells, regulatory osseous cytokines, macrophages, and pericytes.…”

Section: Discussionmentioning

confidence: 99%

“…In this study, the cumulative primary patency rate and cumulative freedom from target lesion revascularization rate was 100% at the 6-month follow-up. 5 Table 2 summarizes stent data for the CFA to date.…”

Section: Discussionmentioning

confidence: 99%

“…Technological developments such as vascular mimetic stents (SUPERA Abbot Vascular Inc, Santa Clara, USA) may be better suited to deal with the eccentric calcified plaques and crush risk attributed to the CFA. 5 In addition, these stents may preserve future endovascular accessibility of the CFA. 5 Recently, data from a randomized controlled trial (TECCO Trial) comparing the safety and efficacy of stenting vs open surgery for de novo CFA stenosis 6 found that perioperative morbidity and mortality was lower among patients who underwent endovascular therapy with stenting compared to surgery.…”

Section: Introductionmentioning

confidence: 99%

“… 5 In addition, these stents may preserve future endovascular accessibility of the CFA. 5 Recently, data from a randomized controlled trial (TECCO Trial) comparing the safety and efficacy of stenting vs open surgery for de novo CFA stenosis 6 found that perioperative morbidity and mortality was lower among patients who underwent endovascular therapy with stenting compared to surgery. 6 Consequently, endovascular treatment of the CFA is gaining more consideration as an alternative treatment to surgery or in patients who are not surgical candidates.…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

SUPERA Stenting in the Common Femoral Artery: Early Experience and Practical Considerations

Tao

Gotra

Tan

et al. 2022

Vasc Endovascular Surg

View full text Add to dashboard Cite

Purpose Endovascular therapy in the management of de novo common femoral disease remains controversial. Considerable interest has been generated in recent years due to recent technological advancement in the design of vascular stents. In particular, SUPERA (Abbot Vascular Inc, Santa Clara USA) stents are designed to offer increased flexibility and less adverse interactions with the arterial wall, thus making it potentially better suited for common femoral lesions. However, despite such theoretical advantages, there is lack of data in its use in clinical practice. This study provides illustrative examples of SUPERA stents in different clinical settings and contributes to important clinical data for the overall efficacy and safety profile of endovascular interventions in common femoral artery (CFA) disease. Materials and Methods Retrospective analysis of all endovascular CFA procedures between January 1, 2011, and December 31, 2019, was conducted. Data collected included demographics, clinical symptoms, medical comorbidities, procedural characteristics, and immediate and short-term complications. Detailed analysis was performed on the stenting cohort. Results During our study period, a total of 69 patients underwent endovascular interventions involving the CFA at our institution, of which 16 patients had stenting procedures for a total of 18 stent deployments. Technical success was achieved in all stenting procedures. A total of 15 SUPERA stents were placed in 13 patients. No stent fractures were observed. Overall primary patency rate of SUPERA stents at the time of 12-month follow-up was 100% in patients who had a follow-up assessment (n = 12 stents). Conclusion Endovascular intervention of the CFA is an evolving topic in the interventional radiology and vascular surgery community. Recent development of newer generation of devices such as SUPERA peripheral stents offers significant potential benefits given their inherent design. Despite the theoretically promising design of the SUPERA, there is a lack of data to support its use. This study contributes important patient-level data for SUPERA stent deployments.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

SUPERA Stenting in the Common Femoral Artery: Early Experience and Practical Considerations

Tao

Gotra

Tan

et al. 2022

Vasc Endovascular Surg

View full text Add to dashboard Cite

show abstract

“…A 6-month cumulative primary patency rate of 100% has been reported with a cumulative freedom from TLR rate of 100%; however, no long-term data are available. 19 The common CFA is frequently used as an arterial access site in endovascular procedures, and a CFA stent placement could potentially compromise future treatment options. Although the puncture through the stent has not been the objective of this study, we observed that there were no complications related to the vascular access site in endovascular procedures up to 8Fr.…”

Section: Discussionmentioning

confidence: 99%

Common Femoral Artery Stenting: Computed Tomography Angiography Based Long-Term Patency

Rabellino

Raleigh

et al. 2021

Vasc Endovascular Surg

View full text Add to dashboard Cite

Background: Despite considerable morbid-mortality rates, common femoral endarterectomy is still considered the gold standard for atherosclerotic common femoral artery (CFA) disease. The aim of this study was to demonstrate computed tomography angiography based long-term patency after CFA stent placement and to analyze associated risk factors for restenosis. Methods: A retrospective and observational study was carried out in consecutive patients treated with endovascular stent placement in CFA lesions. A clinical follow-up and imaging study was performed using MD-CTA to assess different degrees of in stent restenosis (ISR) and primary, assisted, and secondary patency rates. Results: In a 5-year period, 35 extremities were treated in 33 patients with self-expandable nitinol stents. The technical success was 100% without complications related to the procedure. The mean follow-up (FU) was 32.2 months, and 8 limbs were lost. The degree of CFA stenosis was reduced from 79.69 ± 26.47% to 11.23 ± 24.53%. ISR < 20%, 20–70%, and ≥ 70% was evident in 15 (55.6%), 9 (33.3%), and 3 (11.1%) limbs, respectively. Estimated primary, assisted, and secondary patency was 79.5, 96.3, and 96.3%, respectively, after 24 months and 79.5, 96.3, and 96.3%, respectively after 60 months, with a freedom of clinical driven target lesion revascularisation rate of 87.8%. Conclusion: Endovascular treatment with self-expandable nitinol stents in CFA lesions had a high technical success rate and was related to few complications. A mild form of intimal hyperplasia was observed in a considerable number of cases. However, long-term patency was high; therefore, CFA stent placement might be a suitable therapeutic alternative in selected patients.

show abstract

The Specificities of the Common Femoral Artery Anatomy, Calcification and Treatment

Nasr,

Gouëffic

2024

Mastering Endovascular Techniques

View full text Add to dashboard Cite

Endovascular treatment for the common femoral artery: is there a challenger to open surgery?

Cited by 14 publications

References 28 publications

SUPERA Stenting in the Common Femoral Artery: Early Experience and Practical Considerations

SUPERA Stenting in the Common Femoral Artery: Early Experience and Practical Considerations

Common Femoral Artery Stenting: Computed Tomography Angiography Based Long-Term Patency

The Specificities of the Common Femoral Artery Anatomy, Calcification and Treatment

Contact Info

Product

Resources

About